Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.

Pharmaceutical Outsourcing Present and Future

The need for preclinical testing expertise is growing as molecular complexity increases.

Navigating the Preclinical CRO Outsourcing Process

A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.

A Closer Look at Affinity Ligands

Topic

Rita Peters is the former editorial director of 

Pharmaceutical Technology, Pharmaceutical Technology Europe

Articles

Supplier vetting and monitoring-plus comprehensive testing-ensure quality of raw materials.

Locking Fraudulent Materials Out of the Supply Chain

Susan Haigney is lead editor of Pharmaceutical Technology and Pharmaceutical Technology Europe.

Pharmaceutical Technology spoke with Roger Croucher, senior manager, R&D projects, at Catalent Pharma Solutions; Daniel M. Bowles, senior director, chemical development, at Cambrex; and Kurt J Kiewel, director, new product development and analytical services, also at Cambrex about best practices for a successful technology transfer. 

Successful Technology Transfer

Sanjay Konagurthu is senior director, Pharma Services Group at Thermo Fisher Scientific, Bend, Oregon. 

Derek Gallo is director, global technology transfer at Thermo Fisher Scientific, Greenville, SC. 

Successful technology transfer depends on the ability to anticipate risks and plan ahead.

Technology Transfer: Best Practices in Operational Development

Ronak Savla is scientific affairs manager at Catalent Pharma Solutions.

More work needed to advance drug design and development effectively.

Pulling Together to Advance Patient-Focused Drug Products

The company has launched a comprehensive portfolio of custom cell biology solutions and a new cell-line engineering technology.

Lonza Strengthens Cell Capabilities

Belgium-based CDMO MaSTherCell will expand its European manufacturing capacity for cell and gene therapy products by setting up a new facility in Belgium. 

MaSTherCell Announces New Commercial Manufacturing Facility for Cell and Gene Therapies

A $1.7-billion acquisition CDMO Brammer Bio establishes Thermo Fisher Scientific in viral vector manufacturing.

Thermo Fisher Scientific to Acquire Brammer Bio

Walter Colasante is a vice-president in Charles River Associates’ (CRA’s) Life Sciences Practice. 

Pascale Diesel is a vice-president in Charles River Associates’ (CRA’s) Life Sciences Practice.

Think ahead to production requirements when planning strategies in early development of gene and cell therapies.

The Link Between Manufacturing and Commercialization in Gene and Cell Therapy

The companies aim to assess automated CAR-T cell therapy manufacturing at the point-of-care and develop technologies to facilitate patient access to immunotherapies.

Lonza, Sheba to Collaborate on Automated Cell-Therapy Manufacturing

The Pharma Services business of Thermo Fisher Scientific will invest $150 Million at three facilities.